No­var­tis chief Jimenez touts two top PhI­II drug prospects

No­var­tis CEO Joe Jimenez has been busy giv­ing in­ter­views at Davos this week.

In a sit-down with Reuters the Basel-based ex­ec not­ed that Trump …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.